Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study

Archives of Ophthalmology
David S FriedmanPearl German

Abstract

To determine the prevalence and causes of low vision in a large sample of nursing home residents. Twenty-eight nursing homes on the Eastern Shore of Maryland and Delaware were enrolled in a clinical trial to assess the impact of vision restoration/rehabilitation on nursing home residents. Visual acuity was measured using both recognition charts and preferential looking techniques. An ophthalmologist examined all residents with visual acuity worse than 20/40 in the better-seeing eye and determined the primary cause for decreased vision. Results are reported for the better-seeing eye. Of 2544 eligible residents, 1591 (63%) participated, but 286 residents were unable to respond to visual acuity testing. Of the remaining 1307 residents, 496 (37%) had best-corrected visual acuity worse than 20/40 in the better-seeing eye. Causes were ascribed for 412 subjects. Rates of low vision were similar between African American subjects and white subjects (39% and 38%, respectively; age-adjusted P =.18). Cataract was the leading cause of low vision, responsible for 37% of low vision among white subjects and 54% of low vision among African American subjects. Macular degeneration was responsible for 29% of low vision among white subjects but onl...Continue Reading

Citations

Nov 19, 2013·Journal of Comparative Effectiveness Research·Emily W Gower
Nov 30, 2012·Future Medicinal Chemistry·Kai KaarnirantaAntero Salminen
Feb 19, 2013·Immunotherapy·David Xu, Peter K Kaiser
Mar 8, 2012·Future Medicinal Chemistry·Shusheng WangQinbo Zhou
May 9, 2008·Regenerative Medicine·Chris Mason, Peter Dunnill
Feb 18, 2014·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·April Y MaaMary G Lynch
Nov 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Brandon-Luke L SeagleJames R Norris
Jun 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Brandon-Luke L SeagleJames R Norris
Feb 27, 2014·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Sourabh AroraKarim F Damji
Apr 30, 2014·Annual Review of Genomics and Human Genetics·Lars G FritscheAnand Swaroop
Sep 23, 2014·Eye·M Gemenetzi, A J Lotery
Jul 17, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Emmerson BadaroEduardo Buchele Rodrigues
May 25, 2007·The British Journal of Ophthalmology·Cynthia OwsleyAllison Dyer
Jan 23, 2013·Journal of Aging and Health·Amanda F ElliottCynthia Owsley
Oct 21, 2010·Expert Reviews in Molecular Medicine·Sam Khandhadia, Andrew Lotery
Apr 13, 2011·Human Gene Therapy·J Timothy Stout, Peter J Francis
Oct 25, 2011·Nature Genetics·Soumya RaychaudhuriJohanna M Seddon
Mar 5, 2013·Nature Genetics·Lars G FritscheUNKNOWN AMD Gene Consortium
May 21, 2013·Nature Genetics·Johannes P H van de VenAnneke I den Hollander
Oct 19, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Bernard McCarey, Henry Edelhauser
Feb 24, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Carlo E TraversoMargarita Dolgitser
May 22, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·N Andrew WhitlockDennis S Rice
Feb 13, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Erin R RiekeRobert J Lutz
Apr 27, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yong Tao, Jost B Jonas
Nov 3, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Rupal H TrivediCraig E Crosson
Jun 15, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Tarek A Shazly, Mark A Latina
Apr 17, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Gary D NovackNancy E Martin
May 21, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Rogil Jose de Almeida TorresDalton Bertolim Precoma
Jul 9, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kemal YukselAhmet Demirok
Aug 29, 2007·International Journal of Nanomedicine·David G Birch, Fong Qi Liang
Feb 21, 2007·Human Heredity·Gang ZhengRobert C Elston
Oct 5, 2007·Annual Review of Pharmacology and Toxicology·Gary D Novack
Feb 21, 2013·European Journal of Human Genetics : EJHG·Daniel ArdeljanJingsheng Tuo
Sep 7, 2006·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Barkur S Shastry
Oct 20, 2007·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Guy Donati

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

New York State Journal of Medicine
E Gruber
JEMS : a Journal of Emergency Medical Services
A J Rubens
SA Nursing Journal. SA Verplegingstydskrif
J A Liebenberg
Transactions of the Ophthalmological Societies of the United Kingdom
M J Gilkes
© 2022 Meta ULC. All rights reserved